<DOC>
	<DOCNO>NCT00463801</DOCNO>
	<brief_summary>This study evaluate safety efficacy daptomycin complicate skin skin-structure infection adult</brief_summary>
	<brief_title>Safety Efficacy Daptomycin Treatment Complicated Skin Skin-structure Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Staphylococcal Skin Infections</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Inclusion criterion : Subjects diagnosis complicate skin skinstructure infection ( cSSTI ) define infection normally require surgical/local debridement sufficient severity warrant hospitalization intravenous antimicrobial treatment Infection due Grampositive bacteria Hospitalized subject Written inform consent Female patient childbearing potential must negative pregnancy test urine serum baseline must use effective contraception throughout study period . Exclusion criterion : Complicated skin skinstructure infection follow category : Infected burn Severely impaired arterial blood supply Decubitus ulcer Infected diabetic foot ulcer associate osteomyelitis Infected human animal bite Perirectal abscess Necrotising fasciitis gangrene Infections expect require 14 day intravenous antimicrobial therapy Skin and/or skin structure infection treat surgery alone Infections associate permanent prosthetic device remove within 2 day study enrollment Uncomplicated skin soft tissue infection Documented bacteremia baseline Concomitant infection nearby site infection baseline , potentially interfere evaluation Hospitalization condition related rhabdomyolysis Human immunodeficiency virus ( HIV ) cluster differentiation ( CD ) &lt; 200 &lt; 14 % Immune function alteration Lack sufficient purulent material culture Gram test Systemic local antibiotic administration know antiGram positive activity precede 48 hour Complicated skin soft tissue infection ( cSSTI ) know believe related fungal , parasitic viral infection Pneumonia Local systemic know suspected allergy daptomycin Creatinine clearance &lt; 30 mL/min Severe liver damage ( ChildPugh class C ) Alanine transaminase ( ALT ) and/or Aspartate aminotransferase ( AST ) &gt; 3 x Upper limit normal ( ULN ) and/or bilirubin &gt; 1.5 x ULN Use experimental drug precede 30 day Severe medical condition investigator 's opinion could counter indicate participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Complicated Skin Skin-Structure Infections , Daptomycin , MRSA , Diabetic Foot , Abscess , Cellulitis</keyword>
	<keyword>Complicated skin skin-structure infection</keyword>
</DOC>